INTRODUCTION
Until relatively recently, the focus of cancer treatment and research was on the acute treatment of cancer and monitoring for disease recurrence. In 2005, the groundbreaking Institute of Medicine (IOM) report 'Lost in Transition' identified the substantial failure of current follow-up care to comprehensively address the needs of adult cancer survivors. 1 Through the IOM, the distinct needs of adult cancer survivors have been recognised along with the importance of helping survivors live with the longer-term physical, psychological and practical effects of cancer and its treatment. 1 By the broadest definition, a person becomes a cancer survivor when they are diagnosed with cancer, a state that continues throughout the remainder of their life. 1 There are estimated to be more than 25 million cancer survivors worldwide, a number that is projected to increase rapidly due to our ageing population, improved screening leading to earlier detection of cancer and improvements in cancer treatments.
Even cancer survivors with no evidence of disease recurrence experience greater ongoing health problems than the general population. Cancer survivors are known to be at increased risk of cardiovascular disease, type II diabetes, metabolic syndrome and osteoporosis, in addition to the risk of a cancer recurrence or a second primary Open Access cancer. [1] [2] [3] [4] [5] There are a number of identified lifestyle risk factors associated with cancer risk and recurrence and the chronic diseases that accompany them. These lifestyle risk factors are modifiable and include obesity, physical inactivity, smoking and inadequate fruit and vegetable intake. 6 In an attempt to better address the needs of adult cancer survivors, some cancer centres have established survivorship services, centres or clinics. These services are designed to help survivors and their caregivers better manage their disease and any lasting effects of treatment, beyond the period of acute diagnosis and treatment. 5 In addition, many try to facilitate survivors enacting lifestyle changes to increase their physical activity and maintain a healthy weight, in order to aid recovery and improve health-related quality of life (QOL) and possibly for longterm survival. 7 Psychological support is an important feature of most programmes and may include psycho-oncology consultations with a clinical psychologist to manage specific concerns such as fear of cancer recurrence, anxiety or depression; general or disease-specific support groups; or counselling support from allied health professionals. 8 9 The IOM recommended, with the support of a number of peak bodies including the American Society of Clinical Oncology (ASCO), that all cancer survivors transitioning from active to the post-treatment phase should receive an individualised treatment and survivorship care plan (SCP). 1 This should include a summary of cancer treatment received and recommendations regarding future clinical care and coordination, including the frequency and nature of surveillance based on the best available evidence. A number of SCP templates are freely available, including generic and disease specific templates from ASCO and Livestrong, which include information on potential late and long-term effects from the cancer and/or treatment(s). Despite recommendations from oncology organisations that SCP should be used, there is limited evidence that they improve long-term outcomes for cancer survivors although survivor satisfaction with the SCP is generally high. 10 The Sydney Survivorship Centre (SSC) was established in September 2013 at the Concord Cancer Centre in Sydney. It includes (1) a multidisciplinary survivorship clinic for patients with localised cancer who have completed primary treatment with curative intent (eg, surgery, chemotherapy and radiation therapy) without evidence of cancer recurrence and (2) a range of programmes to support lifestyle change. At the initial clinic visit, patients see a multidisciplinary team (MDT) comprising a medical oncologist or haematologist, a cancer nurse specialist, a dietitian, a clinical psychologist and an accredited exercise physiologist (AEP). Prior to attendance at each clinic, patients complete a number of questionnaires assessing symptoms, physical activity, diet, QOL and well-being and are asked to fill in an evaluation after each clinic. Education regarding healthy lifestyle and encouragement to maintain a healthy weight is an important focus of every clinic. An individualised SCP is developed for each oncology patient.
Approximately two-thirds of survivors attend the clinic once and then return to their regular medical team for ongoing follow-up. At the request of the caring team, the remainder continue follow-up through the survivorship clinic. On subsequent visits, they see the medical oncologist and tumour-specific nurse specialist, with referral to other health professionals and/or programmes as required.
In response to the high proportion of survivors who were overweight or obese, and the increasing evidence supporting obesity as a risk factor for cancer recurrence, 11 we established a weight management clinic focused on dietary modification, exercise and behavioural change for those with early stage solid tumours, who have a body mass index >25 kg/m 2 . The intervention was based on a recent systematic review that reported dietary modification involving restrictions of energy and fat intake and promotion of exercise and behavioural changes were the key components for successful weight loss and maintenance. 12 The SSC opened the Survivorship Cottage in May 2014. The cottage is located in the grounds of the hospital, away from the main buildings, and surrounded by gardens and furnished in a homely manner. This is where the majority of the courses are held for cancer survivors at any stage of their cancer journey and their caregivers, with a focus on healthy lifestyle and wellbeing. The Exercise and Nutrition Routine Improving Cancer Health (ENRICH) 13 programme is a 6-week exercise and healthy eating course offered in collaboration with the Cancer Council New South Wales and held regularly throughout the year. Other courses include mindfulness meditation, medical QiGong, yoga, acupuncture, music and art therapy, including scrap-booking, card making, floral design and individual one-off workshops. Courses are selected based on some level of evidence for their efficacy in cancer survivors. [14] [15] [16] [17] [18] [19] [20] The courses are offered weekly for 10 weeks coinciding with school terms, with four terms each year. Commitment to a full term is required. In addition, we provide support groups and public fora on topics of interest to cancer patients and their caregivers and families.
In keeping with the ASCO guidelines, 5 research is an integral component of the survivorship centre. The major research aims of the centre are: (1) to determine the health status, needs, symptoms, QOL and lifestyle characteristics of cancer survivors attending the Sydney Survivorship Clinic or participating in courses; (2) to evaluate changes over time in these variables; (3) to determine risk factors that may affect cancer survivors' clinical outcomes (eg, metabolic syndrome, obesity and inactivity); (4) to evaluate patients' and/or their caregivers/family members' experience with services offered by the SSC, and (5) to evaluate the MDT approach in addressing cancer survivors' needs.
METHODS AND ANALYSIS
This is a single-site longitudinal study led by the Survivorship Research Group, University of Sydney, and the SSC, Concord Cancer Centre. Patient-reported outcome (PRO) data are collected as part of standard care and for quality assurance.
SSC Clinic
The SSC clinic commenced in September 2013.
Eligibility
Medical oncology or haematology patients who have completed primary adjuvant treatment for early stage cancer and have no evidence of a cancer recurrence are eligible to attend the survivorship clinic. Patients with breast cancer may be receiving hormonal treatment and/ or targeted therapy such as trastuzumab. Figure 1 depicts the referral pathway.
Procedure
Prior to attending the survivorship clinic, patients are sent a package containing printed PRO questionnaires assessing symptoms, psychological well-being, distress, QOL, physical activity, dietary intake and performance status. They are asked to bring the completed questionnaires to their appointment. Those with incomplete questionnaires are asked to finalise them during the clinic visit. Patients with insufficient English or poor literacy skills can have assistance from a health translator, family members or clinic staff during the clinic appointment.
Medical information and weight history are obtained from the medical record. Anthropometry (height and weight) is obtained at the initial visit by clinic staff. An SCP is prepared for oncology patients prior to their initial visit, by either the medical oncologist or the registrar. This plan is refined with the patient after consultation with the MDT members and a copy posted to them after the clinic. Haematology patients may receive a detailed letter from the haematologist with recommendations rather than a formal SCP.
Patients are asked to complete an evaluation form after each clinic visit. In addition, those who have given verbal permission to be contacted subsequently will be asked to complete a satisfaction survey over the phone or in person to provide feedback on how useful the SCP has been, how they used it and if it has been revised. This will be approximately 6 months after their initial visit. A subset of patients will be invited to participate in a qualitative interview to explore, in depth, their experience of the survivorship service.
Sydney survivorship courses
The courses were gradually introduced from 2014.
Eligibility
Posters advertising the programmes are displayed in the Concord Cancer Centre waiting areas. Patients with any stage cancer are able to self-refer to participate in survivorship courses. Patients from the Concord Cancer Centre receive priority for courses, but patients from surrounding hospitals are able to attend if space permits. Carers can accompany a patient and participate if space permits.
Measures used for survivorship clinic and courses
Outcome measures used in this study are comprehensive assessments of patient self-report symptoms, QOL, distress and lifestyle factors. The schedule of assessments and details of measures are outlined in table 1a, b.
End points
The global aim of this multifaceted project is to evaluate the SSP clinic and programmes. We aim to assess changes in the end points, stated below, over time. Open Access 
Open Access
Survivorship clinic ► Incidence and severity of symptoms that may be associated with cancer and/or treatment-as assessed by the Patient's Disease and Treatment Assessment Form. 21 This is a 48-item questionnaire assessing symptoms with responses ranging from 0 to 10 (no trouble at all to worst I can imagine) over the previous month. ► Distress-as assessed by the Distress Thermometer. 22 This asks participants to rate their level of distress over the previous week from 0 to 10 (no distress to extreme distress). ► QOL as assessed by the Functional Assessment of Cancer Therapy-General (FACT-G). 23 This 27-item questionnaire assesses physical, social, emotional and functional well-being over the previous week, with ratings from 0 to 4 (not at all to very much). ► Patients' experience with Sydney Survivorship Clinic, developed by the authors, asking patients to rate how useful the session with each member of the MDT was and how well their questions were answered. They also rate how worthwhile it was attending the clinic and give reasons for their answer and comment on the length and timing of the clinic in their cancer journey. Finally, they are asked whether they would recommend the clinic to others and any additional information or services they would have liked to receive. 
Specific SSC programmes
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In-depth qualitative exploration of patient experience Cancer survivors and/or caregivers/family members will be invited to participate in focus group(s) and/or interviews to provide in-depth feedback about their experience of SSC services and information about unmet needs to guide the direction of the SSC clinic or programmes. Both focus groups and telephone interviews are offered to ensure maximum access for individual participants via these flexible options. Consenting individuals will attend a focus group meeting, a face-to-face interview or a telephone interview with staff of the University of Sydney who are not involved in their clinical care. All interviews are semistructured, following an ethics approved interview guide developed for the clinic and each programme.
To monitor changing experiences of the clinic over time, groups of attendees will be purposively sampled periodically on the basis of their disease group, side effect profile and the programmes attended.
Qualitative data will be transcribed verbatim and analysed using thematic analysis.
Data analysis and statistical issues
This protocol describes a data collection process that is ongoing as part of service evaluation. The sample included in each analysis will be dependent on the specific questions asked, with specific hypotheses developed prior to analyses, and the sample size determined for each proposed analysis. The sample size will be determined by attendance of consenting patients at clinics and courses. It is estimated that the survivorship clinic will see 100 new patients per year, of whom 90% will consent to the use of their deidentified data. The first evaluation of initial clinic visits will be performed after 3 years, with an estimated sample size of 300 new patients. This would be considered of clinical significance for determining health status. Approximately 25% of the medical oncology patients receive their follow-up at the survivorship clinic. We will perform a longitudinal analysis once we have a 3-year follow-up for 150 patients. A 3-year disease-free survival is considered a surrogate marker for overall survival for some common tumour types, 30 and this time frame would provide important information on longitudinal health status of survivors.
Outcomes and patient characteristics will be summarised using standard descriptive statistics for each group. Missing data on the PRO will be handled according to the guidelines for each questionnaire. Comparison of results between groups (eg, comparing PRO between tumour types) will be performed using Kruskal-Wallis test for continuous variables, Cochran-Armitage test for trend for ordinal variables and exact χ 2 tests for categorical variables. Spearman rank sum correlation coefficients will be used to determine associations between PROs. Regression modelling may be used to further evaluate associations and to investigate risk factors and predictors of health outcomes.
For longitudinal changes in PROs, a 10% change in the scale from baseline will be considered a clinically meaningful change. 31 A comparison of change over time in symptoms and behaviours will be performed. Changes in PRO at each time point will be analysed, and regression analyses may be subsequently performed for major health status outcomes, to adjust for variables such as time since treatment completion and tumour site.
Qualitative data analysis Interview data will be analysed using thematic analysis with at least two people involved in the analysis. Data coding will occur within a framework using MS Office Excel. 32 Rigour will be ensured through multiple readings of the data, multiple coders, cross-coding and member checking of themes with attendees of the clinic.
DISCUSSION
Survivorship concerns are increasingly recognised as poorly addressed in many standard follow-up appointments. There is considerable debate and a lack of evidence regarding how best to follow-up cancer survivors. Multidisciplinary clinics have the capacity to provide holistic care with a focus on education for lifestyle issues, prevention of long-term side effects and psychological well-being, but they are resource intensive for staff.
Physically active lifestyle and healthy weight have been shown in observational studies to decrease the risk of common cancers and cancer recurrence. Studies have also shown that physical activity and healthy nutrition can improve symptoms associated with cancer treatment and decrease the risk of chronic diseases that are commonly found in cancer survivors, including metabolic syndrome, obesity, type II diabetes, cardiovascular disease and osteoporosis. 33 Although a number of cancer organisations have published recommendations regarding exercise and weight, the majority of patients with cancer are overweight or obese, and most do not meet the guidelines of 150 min/week of moderate intensity physical activity, two sessions of resistance exercise/week and minimising sedentary activities, despite the increasing evidence for benefit. 33 34 This suggests that cancer survivors require additional support and education to facilitate instituting important lifestyle changes.
The SSC has the potential to improve physical and psychological well-being and QOL for cancer survivors. This study will obtain unique data regarding the benefits of an MDT survivorship clinic for patients with cancer who have completed primary adjuvant treatment and evaluation of the courses offered by the SSC for patients at any stage of the cancer journey and their caregivers/ family. This will help determine whether assessing health status and providing education and lifestyle programmes facilitate adoption and adherence to a healthy lifestyle, and whether this can lead to improvement in well-being. Further, it will evaluate the SCP through usage in routine clinical practice, as well as gaining information about who Open Access uses the SSC programmes, and patient (and caregiver) satisfaction with the clinic and courses.
The strengths of the study are that it will provide a large sample size with longitudinal follow-up with comprehensive assessment of health and well-being of cancer survivors attending a multidisciplinary survivorship centre after primary adjuvant treatment. Limitations of the study include that it is an uncontrolled, observational cohort study, with the sample size dependent on the number of patients attending the clinic and programmes who consent to their deidentified data being used.
Ethics approval
Ethics approval has been obtained from Concord Repatriation General Hospital Human Research Ethics Committee (HREC/14/CRGH/23). Patients attending clinics and courses at the SSC are given the option of a tick box to 'opt out' if they do not wish their deidentified data to be used for research purposes.
Dissemination plan
Study results will be disseminated through a series of peer-reviewed publications and conference presentations.
Data storage and security
Questionnaires are part of standard medical care and are kept in patient's oncology subfile. Data are entered into a specifically designed REDCap database, which is password protected and kept on a secure University of Sydney website. Records are identified by a study ID number, and a master list with names kept separately. Data can only be accessed by authorised research team members. Data will be retained in perpetuity after conclusion of the study. After each patient is discharged from the survivorship service through completion of follow-up, disease recurrence or death their data will be fully anonymised by destruction of their details from the master list.
CONCLUSION
Survivorship services are expanding in Australia and globally. The SSC is the only multidisciplinary clinic of its kind in Australia. This study will provide important information about the health status of Australian cancer survivors and enable us to better understand the symptoms, lifestyle and risk factors of our patient population. This will facilitate the design of supportive measures or interventions to better address these issues.
